Literature DB >> 4741873

In vitro observations on sarcoid lymphocytes and their correlation with cutaneous energy and clinical severity of disease.

Y P Kataria, A L Sagone, A G LoBuglio, P A Bromberg.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4741873     DOI: 10.1164/arrd.1973.108.4.767

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  7 in total

Review 1.  Cell-mediated immunity and its role in resistance to infection.

Authors:  E J Wing; J S Remington
Journal:  West J Med       Date:  1977-01

2.  Evidence for a T-cell reaction in the cutaneous sarcoid granuloma.

Authors:  A Alario; J Viac; J Thivolet
Journal:  Arch Dermatol Res       Date:  1977-08-22       Impact factor: 3.017

3.  Immune function in sarcoidosis. Studies on delayed hypersensitivity, B and T lymphocytes, serum immunoglobulins and serum complement components.

Authors:  H Tannenbaum; R E Rocklin; P H Schur; A L Sheffer
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

4.  Immunocompetent cells and delayed hypersensitivity reaction in sarcoidosis.

Authors:  A Arnoux; G Stanislas-Leguern; J Marsac; J Chretien
Journal:  Lung       Date:  1981       Impact factor: 2.584

5.  Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Ali Kanchwala; Carter J H Childs; Yash P Kataria; Marc A Judson; Mark A Mazer; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

6.  Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis.

Authors:  Laura L Koth; Owen D Solberg; Jeffrey C Peng; Nirav R Bhakta; Christine P Nguyen; Prescott G Woodruff
Journal:  Am J Respir Crit Care Med       Date:  2011-08-18       Impact factor: 21.405

7.  Pulmonary sarcoidosis: alterations in bronchoalveolar lymphocytes and T cell subsets.

Authors:  A P Greening; P Nunn; N Dobson; M Rudolf; A D Rees
Journal:  Thorax       Date:  1985-04       Impact factor: 9.139

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.